Teresa Winslow

Teresa Winslow is a respected senior executive and natural collaborator known for utilizing her expertise and extensive experience gained in the Healthcare IT sector as well as in the Life Sciences to significantly impact start-ups, billion-dollar corporations and Boards of Directors. Founder of the Winslow Group, she provides consulting services to Venture/Private equity firms and their portfolio companies in the fast-growing Healthcare IT space and Life Sciences sector. Ms. Winslow’s varied experience provides valuable perspectives for the client companies she engages as well as the Boards of Directors on which she serves.

Her service delivery experience on both the commercial and R&D side of Healthcare IT and Life Sciences, provide a broad context for consulting services with a specialty in coaching entrepreneurs on style and strategy development while working through the issues of managing a fast-growing company are a forte of The Winslow Group.

Ms. Winslow graduated from the University of the Sciences, the Philadelphia College of Pharmacy, and began her career with Eli Lilly & Co., transitioned to Key Pharmaceuticals (acquired by Merck) where she progressed through a series of sales and marketing roles to lead the Dermatology Division.

An entrepreneur by nature, Ms. Winslow joined Dendrite, a pioneer in the development of software applications for pharmaceutical sales force management. Rising to the position of President, Dendrite Americas, she was responsible for 1700 employees on two continents delivering product and services to the top twenty Bio-Pharmas. Over her fifteen-year tenure, Ms. Winslow played a key role as an Officer of the company, in the execution of a successful IPO and growing the company in revenue while generating industry-wide acclaim. While President, Dendrite was ranked 44 among the 100 fastest growing companies in the US by Fortune Magazine.

Utilizing her pharmacy education, Ms. Winslow returned to pharmaceuticals, assuming the role of Divisional Sr. Vice President, Global Business Development in two major Contract Research Organizations, focusing on the Discovery phase through Phase IV Clinical Trials in the drug development continuum.

Ms. Winslow has served in two interim COO roles for clients in the Healthcare IT space and has assumed the Non-Executive Chairman role in two companies (clinical trial revenue management and e-learning for biopharmas respectively) where she was a member of the Board of Directors and sold both companies successfully.

Ms. Winslow has been named “A Policy Maker” by Executive Women of New Jersey, was nominated three times as Business Woman of the Year by the NJ Technology Council, selected as “Alumnae of the Quarter” at the University of the Sciences, and was honored as one of “Five Well-Placed Women” by the Eastern Technology Council.

Ms. Winslow has holds positions on Boards of Directors in the profit and non- profit sectors.